# JBG SMITH Properties: financial statements, quarterly

JBGS · NYSE · CIK 1689796 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jbgs.md) · [Financials](/companies/jbgs/financials.md) · [Filings](/companies/jbgs/filings.md) · [Insiders](/companies/jbgs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jbgs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [152](/filings/0001558370-24-013844.md) | [148 d](/filings/0001104659-26-016450.md) | [145](/filings/0001558370-25-005853.md) | [135](/filings/0001558370-25-009741.md) | [136](/filings/0001104659-25-103188.md) | [131 d](/filings/0001104659-26-016450.md) | [121](/filings/0001104659-26-055649.md) | [126](/filings/0001104659-26-092965.md) | [124](/filings/0001104659-25-103188.md) | [128 d](/filings/0001104659-26-016450.md) | [128](/filings/0001104659-26-055649.md) | [129](/filings/0001104659-26-092965.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [27.9](/filings/0001558370-23-018005.md) | [28.1 d](/filings/0001558370-24-001366.md) | [30.2](/filings/0001558370-24-006272.md) | [32.0](/filings/0001558370-25-009741.md) | [35.3](/filings/0001104659-25-103188.md) | [36.7 d](/filings/0001104659-26-016450.md) | [35.2](/filings/0001104659-26-055649.md) | [35.6](/filings/0001104659-26-092965.md) | [34.8](/filings/0001104659-25-103188.md) | [36.5 d](/filings/0001104659-26-016450.md) | [35.5](/filings/0001104659-26-055649.md) | [36.0](/filings/0001104659-26-092965.md) |
| Income tax | $m | [0.1](/filings/0001558370-24-013844.md) | [(1.0) d](/filings/0001104659-26-016450.md) | [(1.5)](/filings/0001558370-25-005853.md) | [0.6](/filings/0001558370-25-009741.md) | [0.8](/filings/0001104659-25-103188.md) | [0.8 d](/filings/0001104659-26-016450.md) | [(0.2)](/filings/0001104659-26-055649.md) | [(0.1)](/filings/0001104659-26-092965.md) | [0.9](/filings/0001104659-25-103188.md) | [(4.5) d](/filings/0001104659-26-016450.md) | [0.0](/filings/0001104659-26-055649.md) | [0.0 d](/filings/0001104659-26-092965.md) |
| Net income | $m | [(58.0)](/filings/0001558370-24-013844.md) | [(32.6) d](/filings/0001104659-26-016450.md) | [(32.3)](/filings/0001558370-25-005853.md) | [(24.4)](/filings/0001558370-25-009741.md) | [(27.0)](/filings/0001104659-25-103188.md) | [(59.9) d](/filings/0001104659-26-016450.md) | [(45.7)](/filings/0001104659-26-055649.md) | [(19.2)](/filings/0001104659-26-092965.md) | [(28.6)](/filings/0001104659-25-103188.md) | [(45.5) d](/filings/0001104659-26-016450.md) | [(18.7)](/filings/0001104659-26-055649.md) | [(59.2)](/filings/0001104659-26-092965.md) |
| Diluted EPS | $ per share | [(0.58)](/filings/0001558370-24-013844.md) | not reported | [(0.36)](/filings/0001558370-25-005853.md) | [(0.27)](/filings/0001558370-25-009741.md) | [(0.32)](/filings/0001104659-25-103188.md) | not reported | [(0.56)](/filings/0001104659-26-055649.md) | [(0.29)](/filings/0001104659-26-092965.md) | [(0.48)](/filings/0001104659-25-103188.md) | not reported | [(0.32)](/filings/0001104659-26-055649.md) | [(1.03)](/filings/0001104659-26-092965.md) |
| Basic EPS | $ per share | [(0.58)](/filings/0001558370-24-013844.md) | not reported | [(0.36)](/filings/0001558370-25-005853.md) | [(0.27)](/filings/0001558370-25-009741.md) | [(0.32)](/filings/0001104659-25-103188.md) | not reported | [(0.56)](/filings/0001104659-26-055649.md) | [(0.29)](/filings/0001104659-26-092965.md) | [(0.48)](/filings/0001104659-25-103188.md) | not reported | [(0.32)](/filings/0001104659-26-055649.md) | [(1.03)](/filings/0001104659-26-092965.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [131](/filings/0001558370-24-013844.md) | [165](/filings/0001104659-26-016450.md) | [221](/filings/0001558370-25-005853.md) | [164](/filings/0001558370-25-009741.md) | [137](/filings/0001104659-25-103188.md) | [146](/filings/0001104659-26-016450.md) | [81.3](/filings/0001104659-26-055649.md) | [61.4](/filings/0001104659-26-092965.md) | [64.4](/filings/0001104659-25-103188.md) | [75.3](/filings/0001104659-26-092965.md) | [79.8](/filings/0001104659-26-055649.md) | [74.8](/filings/0001104659-26-092965.md) |
| Total assets | $m | [5,666](/filings/0001558370-23-018005.md) | [5,519](/filings/0001558370-25-001099.md) | [5,405](/filings/0001558370-24-006272.md) | [5,325](/filings/0001558370-24-010382.md) | [5,182](/filings/0001558370-24-013844.md) | [5,021](/filings/0001104659-26-016450.md) | [4,733](/filings/0001558370-25-005853.md) | [4,549](/filings/0001558370-25-009741.md) | [4,417](/filings/0001104659-25-103188.md) | [4,388](/filings/0001104659-26-092965.md) | [4,336](/filings/0001104659-26-055649.md) | [4,261](/filings/0001104659-26-092965.md) |
| Total liabilities | $m | [2,817](/filings/0001558370-23-018005.md) | [2,826](/filings/0001558370-25-001099.md) | [2,796](/filings/0001558370-24-006272.md) | [2,854](/filings/0001558370-24-010382.md) | [2,842](/filings/0001558370-24-013844.md) | [2,788](/filings/0001104659-26-016450.md) | [2,743](/filings/0001558370-25-005853.md) | [2,683](/filings/0001558370-25-009741.md) | [2,660](/filings/0001104659-25-103188.md) | [2,719](/filings/0001104659-26-092965.md) | [2,701](/filings/0001104659-26-055649.md) | [2,690](/filings/0001104659-26-092965.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,373](/filings/0001558370-23-018005.md) | [2,223](/filings/0001558370-25-001099.md) | [2,149](/filings/0001558370-24-006272.md) | [2,020](/filings/0001558370-24-010382.md) | [1,882](/filings/0001558370-24-013844.md) | [1,809](/filings/0001558370-25-001099.md) | [1,571](/filings/0001104659-26-092965.md) | [1,323](/filings/0001104659-26-092965.md) | [1,191](/filings/0001104659-25-103188.md) | [1,158](/filings/0001104659-26-092965.md) | [1,140](/filings/0001104659-26-092965.md) | [1,066](/filings/0001104659-26-092965.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.5 d](/filings/0001558370-24-013844.md) | [68.5 d](/filings/0001104659-26-016450.md) | [37.0](/filings/0001558370-25-005853.md) | [23.8 d](/filings/0001558370-25-009741.md) | [26.4 d](/filings/0001104659-25-103188.md) | [42.2 d](/filings/0001104659-26-016450.md) | [12.9](/filings/0001104659-26-055649.md) | [18.8 d](/filings/0001104659-26-092965.md) | [8.9 d](/filings/0001104659-25-103188.md) | [32.6 d](/filings/0001104659-26-016450.md) | [3.4](/filings/0001104659-26-055649.md) | [15.8 d](/filings/0001104659-26-092965.md) |
| Dividends paid | $m | [23.0 d](/filings/0001558370-24-013844.md) | [21.5 d](/filings/0001104659-26-016450.md) | [16.1](/filings/0001558370-25-005853.md) | [16.1 d](/filings/0001558370-25-009741.md) | [15.0 d](/filings/0001104659-25-103188.md) | [14.8 d](/filings/0001104659-26-016450.md) | [14.8](/filings/0001104659-26-055649.md) | [12.4 d](/filings/0001104659-26-092965.md) | [10.8 d](/filings/0001104659-25-103188.md) | [10.4 d](/filings/0001104659-26-016450.md) | [10.4](/filings/0001104659-26-055649.md) | [10.2 d](/filings/0001104659-26-092965.md) |
| Share repurchases | $m | [118 d](/filings/0001558370-24-013844.md) | [61.5 d](/filings/0001104659-26-016450.md) | [49.4](/filings/0001558370-25-005853.md) | [66.9 d](/filings/0001558370-25-009741.md) | [52.0 d](/filings/0001104659-25-103188.md) | [2.4 d](/filings/0001104659-26-016450.md) | [148](/filings/0001104659-26-055649.md) | [225 d](/filings/0001104659-26-092965.md) | [62.9 d](/filings/0001104659-25-103188.md) | [7.9 d](/filings/0001104659-26-016450.md) | [25.4](/filings/0001104659-26-055649.md) | [3.0 d](/filings/0001104659-26-092965.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [114](/filings/0001558370-23-018005.md) | [114](/filings/0001558370-24-006272.md) | [110](/filings/0001558370-24-010382.md) | [101](/filings/0001558370-24-013844.md) | [92.6](/filings/0001558370-25-005853.md) | [91.0](/filings/0001558370-25-009741.md) | [85.3](/filings/0001104659-25-103188.md) | [81.5](/filings/0001104659-26-055649.md) | [68.3](/filings/0001104659-26-092965.md) | [60.6](/filings/0001104659-25-103188.md) | [59.1](/filings/0001104659-26-055649.md) | [58.3](/filings/0001104659-26-092965.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 59,181,298 at 2025-10-24, from the cover of the [10-Q filed 2025-10-28](/filings/0001104659-25-103188.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.